Skip to main content
Fig. 1 | BMC Chemistry

Fig. 1

From: Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties

Fig. 1

Anticancer activity of synthesized compounds compared with Doxorubicin as a standard at different concentrations from 0.048 to 25 μM. a- Compounds 1 and 3–6. b- Compounds 7a–7e. c- Compounds 8a–8e against MCF7 cell line respectively. d -Compounds 1 and 3–6. e -Compounds 7a–7e.f -Compounds 8a–8e against the A549 cell line respectively

Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us